Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Common Stock · CUSIP: H0036K147

Event date: 2024-12-31

Filing-level shares
5,011,857.00
Percent of class
5.2%
  • BlackRock, Inc.

    Shares: 5,011,857.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-000418
Form type
SCHEDULE 13G
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Feb 03, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub